168 related articles for article (PubMed ID: 19169681)
21. 131I SPECT/CT in the follow-up of patients with differentiated thyroid carcinoma.
Menges M; Uder M; Kuwert T; Schmidt D
Clin Nucl Med; 2012 Jun; 37(6):555-60. PubMed ID: 22614186
[TBL] [Abstract][Full Text] [Related]
22. I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients.
Blum M; Tiu S; Chu M; Goel S; Friedman K
Thyroid; 2011 Nov; 21(11):1235-47. PubMed ID: 22007920
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG SPECT/CT in the diagnosis of differentiated thyroid carcinoma with elevated thyroglobulin and negative iodine-131 scans.
Ma C; Wang X; Shao M; Zhao L; Jiawei X; Wu Z; Wang H
Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):220-7. PubMed ID: 24844253
[TBL] [Abstract][Full Text] [Related]
24. Role of Diagnostic
Spanu A; Nuvoli S; Gelo I; Mele L; Piras B; Madeddu G
J Nucl Med; 2018 Oct; 59(10):1510-1515. PubMed ID: 29496990
[TBL] [Abstract][Full Text] [Related]
25. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
[TBL] [Abstract][Full Text] [Related]
26. Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
Bannas P; Derlin T; Groth M; Apostolova I; Adam G; Mester J; Klutmann S
Ann Nucl Med; 2012 Jan; 26(1):77-85. PubMed ID: 22006540
[TBL] [Abstract][Full Text] [Related]
27. [Fusion of SPECT with computed tomography or magnetic resonance for the interpretation of abnormal tracer uptake].
Aqueveque A C; González E P; Gutiérrez B D; Jaimovich F R; Díaz P JC; Csendes G P; Orellana P P; Lavados M H; Alliende G I; Araya L S
Rev Med Chil; 2007 Jun; 135(6):725-34. PubMed ID: 17728898
[TBL] [Abstract][Full Text] [Related]
28. Clinical Implications of Adding SPECT/CT to Radioiodine Whole-Body Scan in Patients With Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
Chong A; Seo Y; Bang JI; Park S; Kim K; Hong CM; Choi M; Oh SW; Lee SW
Clin Nucl Med; 2024 Mar; 49(3):215-225. PubMed ID: 38048517
[TBL] [Abstract][Full Text] [Related]
29. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Monden T; Matsumura Y; Satoh K; Ohkawa M
J Nucl Med; 2003 Dec; 44(12):1905-10. PubMed ID: 14660715
[TBL] [Abstract][Full Text] [Related]
30. Utility of SPECT/CT as an adjunct to planar whole body I-131 imaging: liver metastasis from papillary thyroid cancer.
Agriantonis DJ; Hall L; Wilson MA
Clin Nucl Med; 2009 Apr; 34(4):247-8. PubMed ID: 19300061
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
32. Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.
Fukuoka M; Taki J; Mochizuki T; Kinuya S
Clin Nucl Med; 2011 Jan; 36(1):1-7. PubMed ID: 21157198
[TBL] [Abstract][Full Text] [Related]
33. Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity.
Biermann M; Kråkenes J; Brauckhoff K; Haugland HK; Heinecke A; Akslen LA; Varhaug JE; Brauckhoff M
Acta Radiol; 2015 Nov; 56(11):1350-60. PubMed ID: 25770086
[TBL] [Abstract][Full Text] [Related]
34. Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging?
Avram AM; Fig LM; Frey KA; Gross MD; Wong KK
J Clin Endocrinol Metab; 2013 Mar; 98(3):1163-71. PubMed ID: 23430789
[TBL] [Abstract][Full Text] [Related]
35. The relationship between the quantitative evaluation of thyroid bed uptake and the disappearance of accumulation in adjuvant radioactive iodine therapy for differentiated thyroid cancer.
Konishi K; Ishiba R; Ikenohira T; Asao T; Hirata M; Ohira K; Komatsu T; Sawada M; Tanahashi Y; Goshima S; Magata Y; Nakamura K
Ann Nucl Med; 2021 Feb; 35(2):159-166. PubMed ID: 33387279
[TBL] [Abstract][Full Text] [Related]
36. RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system.
Zeuren R; Biagini A; Grewal RK; Randolph GW; Kamani D; Sabra MM; Shaha AR; Tuttle RM
Laryngoscope; 2015 Oct; 125(10):2417-24. PubMed ID: 25891354
[TBL] [Abstract][Full Text] [Related]
37. Value of ¹³¹I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature.
Xue YL; Qiu ZL; Song HJ; Luo QY
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):768-78. PubMed ID: 23242250
[TBL] [Abstract][Full Text] [Related]
38. SPECT/CT characterization of oral activity on radioiodine scintigraphy.
Savas H; Wong KK; Saglik B; Hubers D; Ackermann RJ; Avram AM
J Clin Endocrinol Metab; 2013 Nov; 98(11):4410-6. PubMed ID: 24001748
[TBL] [Abstract][Full Text] [Related]
39. Postablation (131)I scintigraphy with neck and thorax SPECT-CT and stimulated serum thyroglobulin level predict the outcome of patients with differentiated thyroid cancer.
Ciappuccini R; Heutte N; Trzepla G; Rame JP; Vaur D; Aide N; Bardet S
Eur J Endocrinol; 2011 Jun; 164(6):961-9. PubMed ID: 21471170
[TBL] [Abstract][Full Text] [Related]
40. Incremental value of
Trogrlic M; Težak S
Nuklearmedizin; 2017 Jun; 56(3):97-107. PubMed ID: 28164207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
